Compound ID | 1268

Update compound information

Lysin GN123/Imipenem

Spectrum of activity: Gram-negative
Details of activity: Resensitize P. aeruginosa to imipenem.
Combined with other compounds: Yes
Institute where first reported: ContraFect, ContraFect Corporation, Yonkers, United States
Year first mentioned: 2019
Highest developmental phase: Preclinical
Development status: Active
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/104838
Citation: https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Lysin&id=2173&L=0&x=0&y=0&tx_solr%5Bfilter%5D%5B0%5D=main_filter_eccmid%253Atrue

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.